Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003207546 | SCV003884272 | uncertain significance | Inborn genetic diseases | 2023-02-23 | criteria provided, single submitter | clinical testing | The c.3808A>C (p.K1270Q) alteration is located in exon 34 (coding exon 34) of the IFT172 gene. This alteration results from a A to C substitution at nucleotide position 3808, causing the lysine (K) at amino acid position 1270 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
SN ONGC Dept of Genetics and Molecular biology Vision Research Foundation | RCV003224646 | SCV003920704 | uncertain significance | Bardet-Biedl syndrome | criteria provided, single submitter | research | ||
Fulgent Genetics, |
RCV005029933 | SCV005656024 | uncertain significance | Short-rib thoracic dysplasia 10 with or without polydactyly; Retinitis pigmentosa 71; Bardet-Biedl syndrome 20 | 2024-03-11 | criteria provided, single submitter | clinical testing |